The Isle of Man Looks to Become a Medical Cannabis Hub

Last year, the Isle of Man’s parliament (Tynwald) amended the Misuse of Drugs Act 1976, in order to provide a legal framework for the development of a cannabis industry on the island.  Specifically, the Act now allows the Gambling Supervision Commission (GSC) to except cannabinol, cannabinol derivatives, cannabis, or cannabis resin (other than a medical cannabis product) from the Act’s general prohibitions on the importation, exportation, production, supply or offer to supply, and possession of controlled drugs. Medical cannabis products may be excepted as well, provided the GSC obtains the consent of the Department of Health and Social Care (DHSC).

Although no exception is allowed for cultivation, earlier this year Tynwald approved the Misuse of Drugs (Cannabis) Regulations 2020. Under the Regulations, the GSC may issue licenses for cultivation, as well as other activities, as specified in Schedule 2 and 3 of the Regulations. For example, a class 3 license allows the cultivation of high-THC (more than 0.2%) cannabis in order to sell biomass, live plants, and packaged plant parts. Class 3 licensees must be Isle of Man companies, with the responsible person being a Manx resident. First-year fees are £45,000, going down to £35,000 the second year. Licenses for import

Read More Here…

Share on facebook
Share on twitter
Share on reddit
Share on pinterest
Share on email

Bud Digest

This entry was posted in Vaporizer E-Cigarette Stocks News. Bookmark the permalink. Follow any comments here with the RSS feed for this post. Post a comment or leave a trackback.

Leave a Reply

Your email address will not be published. Required fields are marked *

Your email address will never be published.